Two SSPs issued for Estraderm MX® 25mcg and 100mcg patches
In response to a significant ongoing disruption to the supply of Estraderm MX® 25mcg and 100mcg patches, two new Serious Shortage Protocols (SSPs) have been issued by the Department of Health and Social Care (DHSC). Effective today, 8 September 2022, SSP035 and SSP036 provides that for every Estraderm MX® 25mcg or 100mcg patch originally prescribed, one Evorel® 25mcg patch
Read more